Cognex Corporation filings document regulatory disclosures for an operating company focused on industrial machine vision products and automation technology. Its Form 8-K reports cover furnished operating results, quarterly cash dividends, share repurchase authorization, board and officer matters, annual meeting voting results, and changes in the company’s independent registered public accounting firm.
Proxy materials describe director elections, governance matters, executive compensation, shareholder voting procedures, and board committee oversight. The filing record also includes exhibit-based disclosures tied to financial-results releases and capital-return actions involving Cognex common stock.
Company CGNX reported insider sale activity via a Form 144 notice. The filing lists 61,900 common shares and an aggregate amount of $3,468,385.93 tied to 02/20/2026 on NASDAQ. The excerpt also shows 2,729 restricted shares dated 02/18/2026 and 59,171 shares from a stock option exercise dated 02/20/2026.
COGNEX CORP director Dianne M. Parrotte reported equity award activity involving restricted stock units and common shares. On February 18, 2026, she exercised or converted 8,324 restricted stock units into 8,324 shares of Cognex common stock at a stated price of $0.00 per share, increasing her direct common stock holdings to 30,518 shares.
The filing also lists updated direct holdings of several non-qualified stock options with rights to buy 7,500, 18,400 and 18,100 shares, and 2,913 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Cognex common stock and vests 100% on the first anniversary of the grant date, stated as February 18, 2025.
COGNEX CORP CEO & President Matthew Moschner reported equity awards and vesting activity. On February 18, 2026, 5,085 restricted stock units converted into common stock, with 1,600 shares withheld at $56.7200 per share to satisfy tax withholding obligations.
On February 17, 2026, he received 58,744 non-qualified stock options at an exercise price of $57.0900 and 56,928 restricted stock units, which vest over future anniversaries of the grant date. Following these events he directly holds 93,874 restricted stock units, 11,847 common shares, and options for 697,280 shares.
Cognex Corporation senior vice president and chief financial officer Dennis Fehr reported several equity compensation movements. On February 17, 2026, he was granted 25,306 non-qualified stock options and 24,523 restricted stock units, both at a price of $0.00 per unit. The options vest in five approximately equal annual installments beginning one year after the grant date, while the restricted stock units vest 20%, 30%, and 50% over three years.
On February 18, 2026, 5,085 restricted stock units were converted into the same number of common shares, and 1,618 common shares were disposed of to satisfy tax withholding obligations at $56.72 per share. Following these transactions, Fehr directly owned 14,196 common shares and held 20,339 restricted stock units, along with substantial option holdings.
COGNEX CORP director Angelos Papadimitriou reported equity awards and conversions. On February 18, 2026, he exercised 8,324 restricted stock units at $0.0000 per share into the same number of common shares, bringing his direct common stock holdings to 17,835 shares. On February 17, 2026, he received a grant of 4,817 restricted stock units, which each represent a contingent right to one Cognex common share and vest 100% on the first anniversary of the grant date.
Cognex Corporation’s Chief Technology Officer, Joerg Kuechen, reported several equity-related transactions. On February 18, 2026, 4,056 restricted stock units were converted into an equal number of common shares at $0.00 per share, and 1,327 of those shares were disposed of at $56.72 per share to cover tax withholding obligations rather than through an open‑market sale. After these transactions, he directly held 2,729 shares of common stock. On February 17, 2026, he also received a direct grant of 8,759 new restricted stock units, which vest 100% on the second anniversary of the grant date. Additional non‑qualified stock options and restricted stock units are listed as existing holdings, reflecting his broader long‑term incentive position.
COGNEX CORP director John Tseng-Chung Lee reported equity compensation activity involving restricted stock units and common shares. On February 18, 2026, he exercised 8,324 restricted stock units for 8,324 shares of common stock at a price of $0.00 per share, bringing his direct common stock holdings to 21,907 shares.
On February 17, 2026, he received a grant of 4,817 restricted stock units, and a separate line shows 2,913 restricted stock units held directly after another transaction. Each restricted stock unit represents the right to receive one share of Cognex common stock, with footnotes indicating these awards vest 100% on the first anniversary of their respective grant dates.
COGNEX CORP director Marjorie Sennett reported equity award activity involving restricted stock units and common shares. On February 18, 2026, restricted stock units covering 8,324 shares were exercised for common stock at $0.0000 per share, leaving 23,023 common shares held directly.
On February 17, 2026, she received a grant of 4,817 restricted stock units, each representing a contingent right to one share of common stock. Footnotes state that certain restricted stock unit awards vest 100% on the first anniversary of their respective grant dates.